{
    "success": true,
    "data": {
        "leverage": false,
        "derivates": true,
        "swaps": true,
        "inverse": false,
        "replication_method": "physical",
        "ucits": true,
        "type": "ETF",
        "complex_factors": [
            "Use of financial derivative instruments (FDIs) for direct investment purposes beyond efficient portfolio management (EPM)",
            "Presence of explicit counterparty risk from both derivative use and securities lending",
            "Underlying index employs an 'optimisation process' for ESG and carbon reduction, adding a layer of methodological complexity"
        ],
        "classification": "complex",
        "supporting_data": "The iShares MSCI World Health Care Sector Advanced UCITS ETF is indeed a UCITS product, which generally benefits from a presumption of non-complexity. It primarily employs physical replication by holding the underlying equity securities, which also typically supports a non-complex classification. However, the document explicitly states that 'financial derivative instruments (FDIs) ... may be used for direct investment purposes'. This is a critical factor. Under MiFID II guidelines, if derivatives are integral to achieving the investment objective rather than solely for efficient portfolio management (EPM), the product is classified as complex. Using FDIs for 'direct investment purposes' goes beyond mere EPM and implies they are integral to the fund's strategy, introducing risks (e.g., counterparty risk) that are generally difficult for retail investors to understand. The Key Investor Information document explicitly lists 'Counterparty Risk' as a particular risk, noting that 'The insolvency of any institutions providing services such as safekeeping of assets or acting as counterparty to derivatives or other instruments, may expose the Share Class to financial loss'. This risk is further highlighted by the fund's engagement in securities lending, which, while common, also contributes to counterparty exposure.While the underlying MSCI World Health Care Advanced Select 20 35 Capped Index is based on transparent equity sectors, its 'optimisation process' to reduce carbon emissions intensity, increase ESG score, and minimise tracking error introduces a layer of sophistication to the index methodology. This, combined with the direct use of derivatives, contributes to the overall difficulty for a retail investor with basic knowledge to fully grasp the ETF's structure, risks, and payoff. The MiFID II rules emphasize that complexity is determined by the instrument's structure and the ease with which its risks can be understood. The general rule from the prompt states: 'If any element of Contingent Bonds or any Swap usage is identified then the 'classification' must be 'complex''. While explicit 'swap' usage for direct investment isn't detailed, the broad allowance for FDIs for 'direct investment purposes' suggests instruments that could include swap-like features are within scope, thus triggering this rule."
    }
}